TheProfitWatch

DNLI - Denali Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
17.02 1.09 (6.4%) 0.0 (-0.03%) -0.04 (-0.22%) -0.05 (-0.3%) 0.0 (0.0%) 1.18 (6.97%) 0.0 (0.0%) 0.52 (3.15%)

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.72
Diluted EPS:
-0.72
Basic P/E:
-25.1528
Diluted P/E:
-25.1528
RSI(14) 1m:
56.6
VWAP:
18.11
RVol:

Events

Period Kind Movement Occurred At

Related News